Olmesartan Impurity 57 | CAS 144690-18-6 - Request Quote
Olmesartan Impurity 57
| SZ CAT No: | SZ-O006107 |
| CAS No | 144690-18-6 |
| Mol.F. | C11H18N2O3 |
| Mol.Wt. | 226.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Olmesartan Impurity 57 is chemically Ethyl 2-ethyl-4-(2-hydroxypropan-2-yl)-1H-imidazole-5-carboxylate. Olmesartan Impurity 57 is supplied with detailed characterization data compliant with regulatory guideline. Olmesartan Impurity 57 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Olmesartan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 144690-18-6
Purchase 144690-18-6
Order 144690-18-6
Enquire 144690-18-6
price of 144690-18-6
144690-18-6 Supplier
144690-18-6 Manufacturer
144690-18-6 Exporter
buy high quality Olmesartan Impurity 57
Purchase Olmesartan Impurity 57
Olmesartan Impurity 57 suppliers
Olmesartan Impurity 57 manufacturers
Olmesartan Impurity 57 price
Order Olmesartan Impurity 57
Enquire Olmesartan Impurity 57
Olmesartan Impurity 57 cost
Olmesartan Impurity 57 Supplier
Olmesartan Impurity 57 Distributor
Olmesartan Impurity 57 for Method Validation
Olmesartan Reference Standard
Olmesartan Impurity 57 for ANDA Filing
Olmesartan Impurity 57 for Forced Degradation Studies
Olmesartan Impurity 57 Identification Standards
Olmesartan Impurity 57 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.